Evidence map›Paper›PMID 19220293›Full record

ArticleBritish journal of pharmacology2009

Diadenosine pentaphosphate is a potent activator of cardiac ryanodine receptors revealing a novel high-affinity binding site for adenine nucleotides.

L Song, S M Carter, Y Chen, R Sitsapesan

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Re-evaluation of Diadenosine Tetraphosphate (ApFrontiers in molecular biosciences · 2020
    Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

L SongDepartment of Physiology & Pharmacology, University of Bristol, School of Medical Sciences, University Walk, Bristol, UK.
S M Carter
Y Chen
R Sitsapesan
University of Bristol · GB

Funding

British Heart Foundation
6 · The paper itself

Abstract

background and purposeDiadenosine polyphosphates are normally present in cells at low levels, but significant increases in concentrations can occur during cellular stress. The aim of this study was to investigate the effects of diadenosine pentaphosphate (Ap5A) and an oxidized analogue, oAp5A on the gating of sheep cardiac ryanodine receptors (RyR2). EXPERIMENTAL APPROACH: RyR2 channel function was monitored after incorporation into planar bilayers under voltage-clamp conditions. KEY

resultsWith10 micromol.L(-1) cytosolic Ca2+, a significant 'hump' or plateau at the base of the dose-response relationship to Ap5A was revealed. Open probability (Po) was significantly increased to a plateau of approximately 0.2 in the concentration range 100 pmol x L(-1)-10 micromol x L(-1). High Po values were observed at >10 micromol x L(-1) Ap5A, and Po values close to 1 could be achieved. Nanomolar levels of ATP and adenosine also revealed a hump at the base of the dose-response relationships, although GTP did not activate at any concentration, indicating a common, high-affinity binding site on RyR2 for adenine-based compounds. The oxidized analogue, oAp5A, did not significantly activate RyR2 via the high-affinity binding site; however, it could fully open the channel with an EC(50) of 16 micromol.L(-1) (Ap5A EC(50) = 140 micromol x L(-1)). Perfusion experiments suggest that oAp5A and Ap5A dissociate slowly from their binding sites on RyR2. CONCLUSIONS AND IMPLICATIONS: The ability of Ap5A compounds to increase Po even in the presence of ATP and their slow dissociation from the channel may enable these compounds to act as physiological regulators of RyR2, particularly under conditions of cellular stress.

Indexed as

Adenine NucleotidesAnimalsBinding SitesCalcium Channel AgonistsDinucleoside PhosphatesIn Vitro TechniquesIon Channel GatingLigandsLipid BilayersMyocardiumOxidation-ReductionPatch-Clamp TechniquesPeriodic AcidPhospholipidsRyanodine Receptor Calcium Release ChannelSarcoplasmic ReticulumAdenine NucleotidesCalcium Channel AgonistsDinucleoside PhosphatesLigandsLipid BilayersmetaperiodateP(1),P(5)-di(adenosine-5'-)pentaphosphatePeriodic AcidPhospholipidsRyanodine Receptor Calcium Release Channel

Identifiers

PMID19220293
PMCPMC2697745
OpenAlexW1879829837

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.